Literature DB >> 33737924

Severe Altered Immune Status After Burn Injury Is Associated With Bacterial Infection and Septic Shock.

Hélène Moins-Teisserenc1,2,3,4, Debora Jorge Cordeiro2,5, Vincent Audigier6, Quentin Ressaire1,2,7, Mourad Benyamina2,7, Jérome Lambert1,2,8, Guitta Maki2,5, Laurence Homyrda2,5, Antoine Toubert1,2,3,5, Matthieu Legrand7,9.   

Abstract

Introduction: Burn injury is associated with a high risk of death. Whether a pattern of immune and inflammatory responses after burn is associated with outcome is unknown. The aim of this study was to explore the association between systemic immune and inflammatory responses and outcome in severely-ill burn patients. Materials and
Methods: Innate immunity, adaptive immunity, activation and stress and inflammation biomarkers were collected at admission and days 2, 7, 14, and 28 in severely-ill adult burn patients. Primary endpoint was mortality at day 90, secondary endpoint was secondary infections. Healthy donors (HD) served as controls. Multiple Factorial Analysis (MFA) was used to identify patterns of immune response.
Results: 50 patients were included. Age was 49.2 (44.2-54.2) years, total burn body surface area was 38.0% (32.7-43.3). Burn injury showed an upregulation of adaptive immunity and activation biomarkers and a down regulation of innate immunity and stress/inflammation biomarkers. High interleukin-10 (IL-10) at admission was associated with risk of death. However, no cluster of immune/inflammatory biomarkers at early timepoints was associated with mortality. HLA-DR molecules on monocytes at admission were associated with bacterial infections and septic shock. Later altered immune/inflammatory responses in patients who died may had been driven by the development of septic shock.
Conclusion: Burn injury induced an early and profound upregulation of adaptive immunity and activation biomarkers and a down regulation of innate immunity and stress/inflammation biomarkers. Immune and inflammatory responses were associated with bacterial infection and septic shock. Absence of immune recovery patterns was associated with poor prognosis.
Copyright © 2021 Moins-Teisserenc, Cordeiro, Audigier, Ressaire, Benyamina, Lambert, Maki, Homyrda, Toubert and Legrand.

Entities:  

Keywords:  burns; immunosuppression; inflammation; intensive care; outcome; prognostic

Mesh:

Substances:

Year:  2021        PMID: 33737924      PMCID: PMC7960913          DOI: 10.3389/fimmu.2021.586195

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  29 in total

Review 1.  Fc-receptors as regulators of immunity.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

2.  Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study.

Authors:  Robert Kraft; David N Herndon; Ahmed M Al-Mousawi; Felicia N Williams; Celeste C Finnerty; Marc G Jeschke
Journal:  Lancet       Date:  2012-01-31       Impact factor: 79.321

3.  Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.

Authors:  Guillaume Monneret; Alain Lepape; Nicolas Voirin; Julien Bohé; Fabienne Venet; Anne-Lise Debard; Hélène Thizy; Jacques Bienvenu; François Gueyffier; Philippe Vanhems
Journal:  Intensive Care Med       Date:  2006-06-02       Impact factor: 17.440

Review 4.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 5.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

6.  Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction.

Authors:  Anne-Claire Lukaszewicz; Marion Grienay; Matthieu Resche-Rigon; Romain Pirracchio; Valérie Faivre; Bernadette Boval; Didier Payen
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

Review 7.  Six-of-the-best: unique contributions of γδ T cells to immunology.

Authors:  Pierre Vantourout; Adrian Hayday
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

8.  Elevations in inflammatory cytokines are associated with poor outcomes in mechanically ventilated burn patients.

Authors:  Mehdi C Shelhamer; Matthew P Rowan; Leopoldo C Cancio; James K Aden; Ryan Y Rhie; Gerald A Merrill; Steven E Wolf; Evan M Renz; Kevin K Chung
Journal:  J Trauma Acute Care Surg       Date:  2015-09       Impact factor: 3.313

9.  Comparison of monocyte human leukocyte antigen-DR expression and stimulated tumor necrosis factor alpha production as outcome predictors in severe sepsis: a prospective observational study.

Authors:  Anne M Drewry; Enyo A Ablordeppey; Ellen T Murray; Evan R Beiter; Andrew H Walton; Mark W Hall; Richard S Hotchkiss
Journal:  Crit Care       Date:  2016-10-20       Impact factor: 9.097

10.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Authors:  J Peter Donnelly; Sharon C Chen; Carol A Kauffman; William J Steinbach; John W Baddley; Paul E Verweij; Cornelius J Clancy; John R Wingard; Shawn R Lockhart; Andreas H Groll; Tania C Sorrell; Matteo Bassetti; Hamdi Akan; Barbara D Alexander; David Andes; Elie Azoulay; Ralf Bialek; Robert W Bradsher; Stephane Bretagne; Thierry Calandra; Angela M Caliendo; Elio Castagnola; Mario Cruciani; Manuel Cuenca-Estrella; Catherine F Decker; Sujal R Desai; Brian Fisher; Thomas Harrison; Claus Peter Heussel; Henrik E Jensen; Christopher C Kibbler; Dimitrios P Kontoyiannis; Bart-Jan Kullberg; Katrien Lagrou; Frédéric Lamoth; Thomas Lehrnbecher; Jurgen Loeffler; Olivier Lortholary; Johan Maertens; Oscar Marchetti; Kieren A Marr; Henry Masur; Jacques F Meis; C Orla Morrisey; Marcio Nucci; Luis Ostrosky-Zeichner; Livio Pagano; Thomas F Patterson; John R Perfect; Zdenek Racil; Emmanuel Roilides; Marcus Ruhnke; Cornelia Schaefer Prokop; Shmuel Shoham; Monica A Slavin; David A Stevens; George R Thompson; Jose A Vazquez; Claudio Viscoli; Thomas J Walsh; Adilia Warris; L Joseph Wheat; P Lewis White; Theoklis E Zaoutis; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

View more
  5 in total

Review 1.  Modern Aspects of Burn Injury Immunopathogenesis and Prognostic Immunobiochemical Markers (Mini-Review).

Authors:  Tatyana A Kuznetsova; Boris G Andryukov; Natalia N Besednova
Journal:  BioTech (Basel)       Date:  2022-05-27

2.  sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury.

Authors:  Christian B Bergmann; Cindy B McReynolds; Debin Wan; Nalin Singh; Holly Goetzman; Charles C Caldwell; Dorothy M Supp; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-21       Impact factor: 12.779

3.  Development of a reproducible porcine model of infected burn wounds.

Authors:  Sayf Al-Deen Said; Samreen Jatana; András K Ponti; Erin E Johnson; Kimberly A Such; Megan T Zangara; Maria Madajka; Francis Papay; Christine McDonald
Journal:  J Biol Methods       Date:  2022-02-21

Review 4.  The Role of the Immune System in Pediatric Burns: A Systematic Review.

Authors:  Tomasz Korzeniowski; Paulina Mertowska; Sebastian Mertowski; Martyna Podgajna; Ewelina Grywalska; Jerzy Strużyna; Kamil Torres
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

5.  Severity of thermal burn injury is associated with systemic neutrophil activation.

Authors:  Hendrik Jan Ankersmit; Thomas Haider; Maria Laggner; Marie-Therese Lingitz; Dragan Copic; Martin Direder; Katharina Klas; Daniel Bormann; Alfred Gugerell; Bernhard Moser; Christine Radtke; Stefan Hacker; Michael Mildner
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.